(Press-News.org) BENTLEY UNIVERSITY
New research from the Center for Integration of Science and Industry at Bentley University shows that differences between the financial structures of large pharmaceutical producers and smaller, emerging biotechnology companies creates synergies that contribute to the pipeline of new, innovative products in response to reductions in drug prices anticipated under the Inflation Reduction Act (IRA). While large pharmaceutical producers would likely reduce R&D spending in response to lower product revenues, R&D in smaller biotechnology companies is not likely to decrease and could sustain both corporate profits and new product approvals at current levels. This analysis suggests claims that the IRA would reduce the number of new drugs for unmet medical needs are likely false.
A paper released today titled “Modeling impact of Inflation Reduction Act price negotiations on new drug pipeline considering differential contributions of large and small biopharmaceutical companies,” published in the journal Clinical Trials, showed that for large pharmaceutical producers, which account for the large majority of product sales, revenue, and profit, the level of R&D spending was strongly related to revenue from 2000-2018. In contrast, for smaller biotechnology companies, which typically have few products and little revenue but sponsor the majority of all clinical trials, there was no relationship between R&D spending and revenue. These companies typically acquire capital for R&D substantially through new investment in equity offerings.
This research also assessed the impact of reducing drug pricing on the number of new drug approvals using a drug development pipeline model that considers the differential contributions of large and small companies and likely changes in R&D spending in response to changes in revenue. This analysis suggests the current level of drug approvals could be maintained in the face of global revenue reductions of up to 10% through strategic distribution of cost reductions in large companies between early and late phases of clinical development, coupled with continued acquisition of candidate products in early phases of development by biotechnology companies.
A related working paper titled “Implications of the Inflation Reduction Act for the biotechnology industry; sensitivity of investment and valuation to drug price indices and market conditions,” published by the Institute for New Economic Thinking, showed that there was no relationship between investment in biotechnology and indices of drug prices 2000-2020. This suggests that investment in biotechnology companies is unlikely to be affected by decreases in drug prices and will continue to provide the capital necessary for early-stage innovation and development in biotechnology companies.
These studies describe a dynamic innovation process in which small, emerging biotechnology companies originate the majority of new products and sponsor the majority of all clinical trials with innovation capital arising from private or public investment. These products may then be developed by the biotechnology companies themselves or acquired by large pharmaceutical companies for late-stage development and commercialization. The analysis suggests that the industry can sustain current levels of product approval and commercialization without compromising corporate earnings or investor returns.
These studies do not support industry arguments that drug price reductions anticipated by the IRA represent a threat to corporate profits, investor returns, or new product approvals.
“Pharmaceutical innovation is not adequately described by conventional economic theories that fail to account for the distinct business models of small, science-based biotechnology companies” said Fred Ledley, Director of the Center for Integration of Science and Industry, and the senior author on these studies. “Our work suggests that established management and investment practices could preserve both the industry’s profits and current levels of drug approvals in face of the reductions in drug price anticipated by the Inflation Reduction Act.”
Dr. Gregory Vaughan, Associate Professor of Mathematical Sciences at Bentley University, was the lead author of the publication in Clinical Trials along with Roger Du and Dr. Ledley. Dr. Cody Hyman, Assistant Professor of Accounting at Bentley University, was the lead author of the working paper published by INET along with Henry Dao, Dr. Vaughan, and Dr. Ledley. Roger Du and Henry Dao worked as undergraduate researchers at Bentley University.
This work was funded by the West Health Policy Center and National Biomedical Research Foundation through grants to Bentley University.
CENTER FOR INTEGRATION OF SCIENCE AND INDUSTRY at Bentley University focuses on advancing the translation of scientific discoveries to create public value. The Center is an environment for interdisciplinary scholarship spanning basic science, data analytics, business, and public policy. For more information, visit bentley.edu/sciindustry and follow us on Twitter/X and LinkedIn. The Center for Integration of Science and Industry is an affiliate of the Center for Health and Business at Bentley University.
BENTLEY UNIVERSITY is more than just one of the nation's top business schools. It is a lifelong-learning community that creates successful leaders who make business a force for positive change. With a combination of business and the arts and sciences and a flexible, personalized approach to education, Bentley provides students with critical thinking and practical skills that prepare them to lead successful, rewarding careers. Founded in 1917, the university enrolls 4,100 undergraduate and 1,000 graduate and PhD students and is set on 163 acres in Waltham, Massachusetts, 10 miles west of Boston. For more information, visit bentley.edu. Follow us on Twitter/X #BentleyUResearch.
END
Biotechnology companies can sustain the pipeline of new drugs under the Inflation Reduction Act
Differences in the financial structure of large pharmaceutical producers and smaller biotechnology companies create resiliency
2024-07-26
ELSE PRESS RELEASES FROM THIS DATE:
65 million Americans now own firearms for protection, suggests survey
2024-07-26
Some 65 million Americans now own firearms for protection—around 80% of the country’s estimated 81 million gun owners—suggest the results of a nationally representative survey carried out in 2023, and published online in the journal Injury Prevention.
This perceived need is changing the profile of gun owners, the findings indicate, with increasing numbers of women and those of minority ethnic backgrounds citing protection as the primary reason for owning a firearm.
In 2021, firearms caused the highest ...
More than 10-fold difference in rates of unintentional gun deaths across US states
2024-07-26
There’s more than a 10-fold difference in the rates of unintentional gun deaths across US states, with such incidents claiming more than 12,000 lives between 2001 and 2021, finds research published online in the journal Injury Prevention.
Poverty, rural residency, non-White ethnicity and firearms ownership are all associated with higher rates, the findings show.
Firearms kill over 130 Americans every day. Most of these deaths are intentional, but of the 48,830 firearm related deaths in 2021, 549 were unintentional, note the researchers. But it’s not clear if rates differ within and between states.
To explore this further, the researchers looked ...
Unplanned pregnancies among active service women likely curb US military readiness
2024-07-26
Unplanned pregnancies among active service women may be curbing overall US military readiness for action and compromising its Women Peace and Security objectives, suggests research published online in the journal BMJ Military Health.
That’s because they potentially result in the loss of an estimated 2.5 million to more than 4.5 million active duty days, depending on the denominator used, the findings indicate, with the highest rates among 18-24 year olds, those of White race, those deployed in junior ranks and those serving in the Army.
The researchers set out to assess the impact ...
High levels of ozone and grass pollen expected for Paris Olympics/Paralympics
2024-07-26
High levels of the respiratory irritant ozone and grass pollen are likely during the 2024 Olympic and Paralympic Games if hot, sunny weather prevails, suggests an analysis of historic air quality monitoring data for the city of Paris and surrounding area during previous summers, and published online in the British Journal of Sports Medicine.
Athletes can be affected by environmental factors, despite generally being in good physical condition, note the researchers. Breathing in air pollution during exercise may pose health risks, depending on exposure levels and underlying long term conditions, they add. Endurance athletes are particularly susceptible to allergic symptoms, they say.
To ...
CDA creates new industry partner program
2024-07-26
The University of Illinois Center for Digital Agriculture (CDA) has launched a new partnership program for industry members to strengthen their ties to academia, technology, multidisciplinary research and professional development in a joint effort to tackle the globe’s most pressing agricultural challenges.
Unveiled in June, the CDA Industry Partner Program (IPP) offers members the opportunity to collaborate with world-renowned researchers and field experts to solve complex problems facing the industry, whether they stem from a changing climate, personnel shortages or any other hurdles that spring up. IPP ...
Tulane study says new drug shows promise in clearing HIV from brain
2024-07-26
An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new Tulane University study.
For the first time, researchers at Tulane National Primate Research Center found that a cancer drug significantly reduced levels of SIV, the nonhuman primate equivalent of HIV, in the brain by targeting and depleting certain immune cells that harbor the virus.
Published in the journal Brain, this discovery marks a significant step toward eliminating HIV from hard-to-reach reservoirs where the virus evades otherwise effective treatment.
“This research is an important step ...
Medicaid policies increase diverse participation in cancer clinical trials
2024-07-25
Two Medicaid policies can interact to increase oncology clinical trial enrollment among Black and Hispanic patients, according to a new study by investigators at Weill Cornell Medicine, the University of Pennsylvania, and Medidata AI. Black and Hispanic patients are historically underrepresented in cancer clinical trials; equitable enrollment helps ensure the knowledge gained from trials generalizes to the entire population and promotes equitable patient access to the latest treatment options.
The study, published July 25 in the Journal of Clinical Oncology, examined the effect of the interaction between two Medicaid policies on the rates of enrollment for Black ...
Study identifies unique treatment preference profiles in men with prostate cancer
2024-07-25
A team of investigators from UCLA has identified distinct patient preference-based profiles among men diagnosed with low-risk prostate cancer regarding their treatment options that could help enhance shared decision-making and patient satisfaction in prostate cancer care.
The study, published in Urology Practice, reveals that while there were clear differences in treatment preferences among the profiles, these preference profiles did not significantly influence the patients' final treatment choices.
“Men ...
Parched Central Valley farms depend on Sierras for groundwater
2024-07-25
New research shows that California’s Central Valley, known as America’s breadbasket, gets as much as half of its groundwater from the Sierra Nevadas. This is significant for a farming region that, in some parts, relies almost entirely on groundwater for irrigation.
While it is easy to see above-ground reservoirs rise and fall with the rain and snow, aquifers are a natural water source hidden out of sight, in some cases hundreds of feet underground. “They are like giant bathtubs full of water and sediment,” said UC Riverside associate professor of groundwater hydrology Hoori Ajami.
Scientists have ...
NYUAD researcher receives National Science Foundation grant to study the role of tiny diatoms in protecting endangered marine animals
2024-07-25
Abu Dhabi, UAE, July 25, 2024: NYU Abu Dhabi (NYUAD) Associate Professor of Biology Shady Amin has received a grant of more than USD 500,000 from the National Science Foundation (NSF). He will lead a project that is aimed at elevating the understanding and awareness of the essential role played by diatoms, the tiny microalgae that can live in oceans or in symbiosis with endangered marine animal hosts like whales, dolphins, dugongs, and manatees and play a fundamental role in maintaining Earth’s delicate ecosystem.
Diatoms are microalgae ...
LAST 30 PRESS RELEASES:
Insulin resistance is linked to over 30 diseases – and to early death in women, study of people in the UK finds
Innovative semaglutide hydrogel could reduce diabetes shots to once a month
Weight loss could reduce the risk of severe infections in people with diabetes, UK research suggests
Long-term exposure to air pollution and a lack of green space increases the risk of hospitalization for respiratory conditions
Better cardiovascular health in early pregnancy may offset high genetic risk
Artificial intelligence method transforms gene mutation prediction in lung cancer: DeepGEM data releases at IASLC 2024 World Conference on Lung Cancer
Antibody–drug conjugate I-DXd shows clinically meaningful response in patients with extensive-stage small cell lung cancer
IASLC Global Survey on biomarker testing reveals progress and persistent barriers in lung cancer biomarker testing
Research shows pathway to developing predictive biomarkers for immune checkpoint inhibitors
Just how dangerous is Great Salt Lake dust? New research looks for clues
Maroulas appointed Associate Vice Chancellor, Director of AI Tennessee
New chickadee research finds cognitive skills impact lifespan
Cognitive behavioral therapy enhances brain circuits to relieve depression
Terasaki Institute awarded $2.3 Million grant from NIH for organ transplantation research using organs-on-a-chip technology
Atoms on the edge
Postdoc takes multipronged approach to muon detection
Mathematical proof: Five satellites needed for precise navigation
Scalable, multi-functional device lays groundwork for advanced quantum applications
Falling for financial scams? It may signal early Alzheimer’s disease
Integrating MRI and OCT for new insights into brain microstructure
Designing a normative neuroimaging library to support diagnosis of traumatic brain injury
Department of Energy announces $68 million in funding for artificial intelligence for scientific research
DOE, ORNL announce opportunity to define future of high-performance computing
Molecular simulations, supercomputing lead to energy-saving biomaterials breakthrough
Low-impact yoga and exercise found to help older women manage urinary incontinence
Genetic studies reveal new insights into cognitive impairment in schizophrenia
Researcher develops technology to provide cleaner energy and cleaner water
Expect the unexpected: nanoscale silver unveils intrinsic self-healing abilities
nTIDE September 2024 Jobs Report: Gains in employment for people with disabilities appear to level off after reducing gaps with non-disabled workers
Wiley enhances NMR Spectral Library Collection with extensive new databases
[Press-News.org] Biotechnology companies can sustain the pipeline of new drugs under the Inflation Reduction ActDifferences in the financial structure of large pharmaceutical producers and smaller biotechnology companies create resiliency